Metraipolis › archive › dc_019dcfe50af6

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria — Europe PMC PMID:36963010

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36963010
DOI
10.1371/journal.pgph.0001313
License (as archived)
CC0-1.0
Archived
2026-10-07T20:45:37.797Z
SHA-256 of the archived text
75ace8b92f275a4a58fd1a7bef8ee78d7a36e8bd9cafaf45b0b7bfe1d4c23152
Stable URL of this page
https://metraipolis.com/documento/dc_019dcfe50af6

How to cite

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria — Europe PMC PMID:36963010 — Europe PMC (en), https://europepmc.org/article/MED/36963010 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_019dcfe50af6 (Metraipolis archive dc_019dcfe50af6, sha256 75ace8b92f275a4a58fd1a7bef8ee78d7a36e8bd9cafaf45b0b7bfe1d4c23152)
BibTeX
@misc{dc019dcfe50af6,
  title = {A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria — Europe PMC PMID:36963010},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36963010},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_019dcfe50af6; sha256 75ace8b92f275a4a58fd1a7bef8ee78d7a36e8bd9cafaf45b0b7bfe1d4c23152},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36963010. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

As of 2018, cryptococcal antigen (CrAg) screening in patients with advanced human immunodeficiency virus (HIV) disease (AHD) was not routinely implemented in Nigeria despite being recommended in the national HIV treatment guidelines. Our aim was to determine the prevalence and risk factors for asymptomatic cryptococcal antigenemia in adult people living with HIV (PLHIV) in Nigeria to advocate for the implementation of routine CrAg screening. A descriptive cross-sectional study and CrAg screening of consecutive adult PLHIV with CD4 counts ≤200 cells/μL was conducted from April 2018 to April 2019 at HIV clinics in eleven tertiary hospitals spread across Nigeria's six geopolitical regions. Prevalence of asymptomatic cryptococcal antigenemia was estimated by facility and geopolitical zone. Logistic regression was conducted to identify risk factors for cryptococcal antigenemia. In total, 1,114 patients with AHD were screened. The overall prevalence of asymptomatic cryptococcal antigenemia was 3.9% with wide variation across facilities (range: 0/75 [0%]- 15/122 [12.3%]) and geopolitical zones (range: 0/75 [0%]-19/279 [6.8%]). Prevalence of antigenemia was highest in the South-West (19/279 [6.8%]) and lowest in the North-East (0/75 [0%]). Prevalence was 5.2% (26/512) and 3.2% (18/561) in patients with CD4<100 and CD4 of 101-200, respectively. Of all patients with antigenemia, 50% were on antiretroviral therapy (ART) at the time of having a positive CrAg test. In adjusted analysis, cryptococcal antigenemia was significantly less in patients on ART and patients who had completed any formal education. The survey showed a high overall burden of cryptococcal antigenemia in Nigeria, with variable prevalence across geopolitical regions. We provided valuable evidence for implementing routine CrAg screening of AHD patients in Nigeria which has commenced in selected centres.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLOS global public health, 2023 (prima pubblicazione 2023-01-31).
Identificativi: PMID 36963010 · PMCID PMC10021610 · DOI 10.1371/journal.pgph.0001313.
Pagina: https://europepmc.org/article/MED/36963010 — https://doi.org/10.1371/journal.pgph.0001313. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T20:06:11.220Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.